Correlation Between Alphabet and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Alphabet and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and NewAmsterdam Pharma, you can compare the effects of market volatilities on Alphabet and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and NewAmsterdam Pharma.
Diversification Opportunities for Alphabet and NewAmsterdam Pharma
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Alphabet and NewAmsterdam is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Alphabet i.e., Alphabet and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Alphabet and NewAmsterdam Pharma
Given the investment horizon of 90 days Alphabet Inc Class C is expected to under-perform the NewAmsterdam Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Alphabet Inc Class C is 5.26 times less risky than NewAmsterdam Pharma. The stock trades about 0.0 of its potential returns per unit of risk. The NewAmsterdam Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 956.00 in NewAmsterdam Pharma on August 28, 2024 and sell it today you would earn a total of 59.00 from holding NewAmsterdam Pharma or generate 6.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Alphabet Class C |
| NewAmsterdam Pharma |
Alphabet and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and NewAmsterdam Pharma
The main advantage of trading using opposite Alphabet and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.The idea behind Alphabet Inc Class C and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NewAmsterdam Pharma vs. NewAmsterdam Pharma | NewAmsterdam Pharma vs. Scilex Holding | NewAmsterdam Pharma vs. OmniAb Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets |